key: cord-0078351-p3chxvsv
authors: Garcia Castro, Jesús; Utrilla Contreras, Cristina; Martín Montes, Ángel
title: Reversible Cytotoxic Lesion of the Corpus Callosum and COVID-19
date: 2022-05-17
journal: Neurohospitalist
DOI: 10.1177/19418744211039374
sha: 9008cbd4be641ffa093da48df6d7a70b095aa7a7
doc_id: 78351
cord_uid: p3chxvsv

nan

A 62-year-old male with history of hypertension and diabetes mellitus who was being followed in the Neurology outpatient clinic due to mild cognitive impairment of several years of evolution was hospitalized in late September 2020 after SARS-CoV-2 infection. He was discharged after eleven days following a favorable clinical course. The patient did not present any neurological manifestation during hospitalization. A cerebral magnetic resonance image (MRI), requested prior to hospital admission, was performed in November 2020 showing a fluid-attenuated inversion recovery (FLAIR) hyperintense lesion in the splenium of the corpus callosum with restricted diffusion (Figure 1 CLOCC is a nonspecific clinico-radiological entity that has been associated to a high variety of etiologies such as infection, epilepsy, metabolic disorders, and certain drugs. [1] [2] [3] [4] The typical appearance on MRI is that of a reversible hyperintensity in FLAIR images with restricted diffusion in the splenium of the corpus callosum. 5 Although not yet fully established, the proposed mechanism underlying CLOCC might be related to neuron swelling as a result of the release of cytokines. The process would lead an influx of water and Na+ in neurons and glial cells, conducting to cytotoxic edema. 1, 5 The prominent role played by the release of cytokines in COVID-19 could conform to the pathophysiological hypothesis of CLOCCs. 6 

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Jesus Garcia Castro  https://orcid.org/0000-0003-1503-4775

Reversible lesion in the splenium of the corpus callosum

Cytotoxic lesions of the corpus callosum (CLOCCs) associated with SARS-CoV-2 infection

Teaching NeuroImages: cytotoxic lesions of the corpus callosum in encephalopathic patients with COVID-19

COVID-19-associated cytotoxic lesions of the corpus callosum

Cytotoxic lesions of the corpus callosum that show restricted diffusion: Mechanisms, causes, and manifestations

Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts

Figure 2. Follow-up MR imaging performed 3 months later showed almost complete resolution of the abnormal signal on axial FLAIR (A), DWI (B) and ADC map (C)